Ｂａｙｅｒ公司打算在未来５年内每年投资１０亿美元用于其美国的制药，非处方药和诊断试剂业务，这笔资金中一大部分用于药物的研究与开发。 该公司称，此项投资是于１９９５～２００４这１０年中在美国投资超过１５０亿美元计划的一部分。该计划包括８３亿美元研究开发费用和 Bayer plans to invest $1 billion a year in its U.S. pharmaceutical, over-the-counter, and diagnostic reagent businesses over the next five years. A large portion of this funding will be spent on drug research and development. The company said that this investment was part of a plan to invest more than $15 billion in the United States during the decade from 1995 to 2004. The plan includes $8.3 billion in research and development costs and